Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Cadwallader AB"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Cadwallader AB; Director of regulatory and public policy development at US Pharmacopeia., Nallathambi K; Senior advisor on policy and advocacy for Project Hope., Ching C; US Pharmacopeia Quality Institute fellow.
Publikováno v:
AMA journal of ethics [AMA J Ethics] 2024 Jun 01; Vol. 26 (6), pp. E472-478. Date of Electronic Publication: 2024 Jun 01.
Autor:
Perlino C; Vice president of federal programs drug policy at America's Health Insurance Plans., Daniel H; Senior regulatory affairs policy manager for US Pharmacopeia., Cadwallader AB; Director of regulatory and public policy development at US Pharmacopeia.
Publikováno v:
AMA journal of ethics [AMA J Ethics] 2024 Apr 01; Vol. 26 (4), pp. E282-288. Date of Electronic Publication: 2024 Apr 01.
Autor:
Nallathambi K; Former senior manager of global public policy at US Pharmacopeia., Cadwallader AB; Director of regulatory and public policy development at US Pharmacopeia.
Publikováno v:
AMA journal of ethics [AMA J Ethics] 2024 Apr 01; Vol. 26 (4), pp. E289-294. Date of Electronic Publication: 2024 Apr 01.
Autor:
Cadwallader AB; Director of regulatory and public policy development at US Pharmacopeia.
Publikováno v:
AMA journal of ethics [AMA J Ethics] 2024 Apr 01; Vol. 26 (4), pp. E277-281. Date of Electronic Publication: 2024 Apr 01.
Autor:
Richardson E; Director of the Health Care Products Project at the Pew Charitable Trusts in Washington, DC., Akkas F; Senior associate at the Pew Charitable Trusts., Cadwallader AB; Director of regulatory and public policy development for the US Pharmacopoeia.
Publikováno v:
AMA journal of ethics [AMA J Ethics] 2022 May 01; Vol. 24 (5), pp. E402-409. Date of Electronic Publication: 2022 May 01.
Autor:
Cadwallader AB; Director of regulatory and public policy development for the US Pharmacopoeia., Council On Science And Public Health A; Advises the American Medical Association on substantial and promising developments in the fields of science and public health and develops reports and policy positions on the scientific aspects of medicine, biomedical research, and public health.
Publikováno v:
AMA journal of ethics [AMA J Ethics] 2022 May 01; Vol. 24 (5), pp. E410-418. Date of Electronic Publication: 2022 May 01.
Autor:
Cadwallader AB; Director of regulatory and public policy development for the US Pharmacopoeia.
Publikováno v:
AMA journal of ethics [AMA J Ethics] 2022 May 01; Vol. 24 (5), pp. E443-451. Date of Electronic Publication: 2022 May 01.
Autor:
Davis GG; From the Department of Pathology, University of Alabama at Birmingham, Birmingham, AL., Cadwallader AB; Science and Drug Policy, American Medical Association, Chicago, IL., Fligner CL; Department of Pathology, University of Washington, Seattle, WA., Gilson TP; Cuyahoga County Medical Examiner's Office, Cleveland, OH., Hall ER; Coroner's Office, Boulder County, Boulder, CO., Harshbarger KE; Coroner's Office, Montgomery County, Dayton, OH., Kronstrand R; Department of Forensic Genetics and Forensic Toxicology, National Board of Forensic Medicine, Linköping, Sweden., Mallak CT; Broward County Office of Medical Examiner and Trauma Services, Fort Lauderdale, FL., McLemore JL; Department of Pathology, Wake Forest School of Medicine, Winston-Salem, NC., Middleberg RA; NMS Labs, Horsham, PA., Middleton OL; Hennepin County Medical Examiner's Office, Minneapolis, MN., Nelson LS; Emergency Medicine and Medical Toxicology, Rutgers New Jersey Medical School, Newark, NJ., Rogalska A; Dane County Medical Examiner's Office, McFarland, WI., Tonsfeldt E; Clackamas County Medical Examiner's Office, Clackamas, OR., Walterscheid JP; Armed Forces Medical Examiner System, Dover, DE., Winecker RE; Laboratory Quality Assurance and Proficiency Program, RTI International, Research Triangle Park, NC.
Publikováno v:
The American journal of forensic medicine and pathology [Am J Forensic Med Pathol] 2020 Sep; Vol. 41 (3), pp. 152-159.
Autor:
Morrow JB; Material Measurement Laboratory, National Institute of Standards and Technology, 100 Bureau Drive, Gaithersburg, MD, USA., Ropero-Miller JD; RTI International, Research Triangle Park, NC, USA., Catlin ML; National Heroin Coordination Group, Office of National Drug Control Policy, Washington, DC, USA., Winokur AD; Office of Forensic Sciences for the Drug Enforcement Administration's (DEA) Southeast Laboratory, Miami, FL, USA., Cadwallader AB; Council on Science and Public Health, American Medical Association, Chicago, IL, USA., Staymates JL; Material Measurement Laboratory, National Institute of Standards and Technology, 100 Bureau Drive, Gaithersburg, MD, USA., Williams SR; Office of Special Programs, National Institute of Standards and Technology, 100 Bureau Drive, Gaithersburg, MD, USA., McGrath JG; DOJ National Institute of Justice, Office of Investigative and Forensic Sciences, Washington, DC, USA., Logan BK; NMS Labs, Willow Grove, PA, USA., McCormick MM; US Customs and Border Protection, Washington, DC, USA., Nolte KB; Pathology and Radiology, New Mexico Office of the Medical Investigator, Albuquerque, NM, USA., Gilson TP; Cuyahoga County Regional Forensic Sciences Laboratory, Cleveland, OH, USA., Menendez MJ; Organized Crime Drug Enforcement Task Forces, Department of Justice, Washington, DC, USA., Goldberger BA; University of Florida, Gainesville, FL, USA.
Publikováno v:
Journal of analytical toxicology [J Anal Toxicol] 2019 Jan 01; Vol. 43 (1), pp. 1-9.